6
Views
5
CrossRef citations to date
0
Altmetric
Original Article

An Evaluation of Anabolic-Androgenic Steroid Abusers Over a Period of 1 Year: Seven Case Studies

, , , &
Pages 121-130 | Published online: 04 Dec 2011

References

  • Kanayama G, Gruber AJ, Pope HG, Jr, Borowiecki JJ, Hudson JI: Over-the-counter drug use in gymnasiums: An under recog-nized substance abuse problem? Psychother Psychosom 2001; 70:137–140
  • Wagner JC: Enhancement of athletic performance with drugs. An overview. Sports Med 1991; 12:250–265
  • Johnson MD: Anabolic steroid use in adolescent athletes. Pediatr Clin North Am 1990; 37:1111–1123
  • Brower KJ, Blow FC, Hill EM: Risk factors for anabolic-androgenic steroid use in men. J Psychiatr Res 1994; 28:369–380
  • Dickerman RD, McConathy WJ, Schaller F, Zachariah NY: Cardiovascular complications and anabolic steroids. Eur Heart J 1996; 17:1912
  • Rockhold RW: Cardiovascular toxicity of anabolic steroids. Annu Rev Pharmacol Toxicol 1993; 33:497–520
  • Parssinen M, Seppala T: Steroid use and long-term health risks in former athletes. Sports Med 2002; 32:83–94
  • Sullivan ML, Martinez CM, Gennis P. Gallagher EJ: The car-diac toxicity of anabolic steroids. Prog Cardiovasc Dis 1998; 41:1–15
  • Wu FC: Endocrine aspects of anabolic steroids. Clin Chem 1997; 43:1289–1292
  • Narducci WA, Wagner JC. Hendrickson TP, Jeffrey TP: An-abolic steroids—A review of the clinical toxicology and diag-nostic screening. J Toxicol Clin Toxicol 1990; 28:287–310
  • Bjorkqvist K, Nygren T, Bjorklund A. Bjorkqvist S: Testos-terone intake and aggressiveness. Aggress Behav 1994; 20:17–26
  • Brower KJ, Eliopulos GA. Blow FC, Catlin DH, Beresford TP: Evidence for physical and psychological dependence on anabolic androgenic steroids in eight weight lifters. Am J Psy-chiatry 1990; 147:510–512
  • Choi PYL. Parrott AC, Cowan D: High-dose anabolic steroids in strength athletes: Effects upon hostility and aggression. Hum Psychopharmacol 1990; 5:349–356
  • Kouri EM, Lukas SE, Pope HG, Jr, Oliva PS: Increase aggres-sive responding in male volunteers following the administra-tion of gradually increasing doses of testosterone cypionate. Drug Alcohol Depend 1995: 40:39–73
  • Malone DA, Jr, Dimeff R, Lombardo JA, Sample BRH: Psy-chiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clin I Sports Med 1995; 5:25–31
  • Moss HB, Panzak GL, Tarter RE: Personality, mood, and psy-chiatric symptoms. Am J Addict 1992; 1:315–324
  • Parrott A, Choi PYL, Davies M: Anabolic steroid use by ama-teur athletes: Effects upon psychological mood states. J Sports Med Phys Fitness 1994; 34:292–298
  • Pope HG, Jr, Katz DL: Psychiatric and medical effects of anabolic—androgenic steroid use. Arch Gen Psychiatry 1994; 51:375–382
  • Su TP, Pagliaro M, Schmidt PJ,Pikar D, Wolkowitz O, Rubinow DR: Neuropsychiatric effects of anabolic steroids in male nor-mal volunteers. JAMA 1993; 269:2760–2764
  • Yesalis CE, Herrick RT, Buckley WE, Fried KE, Brannon D, Wright JE: Self-reported use of anabolic—androgenic steroids by elite power lifters. Phys Sports Med 1988; 16:91–100
  • Gruber AJ, Pope HG, Jr: Psychiatric and medical effects of anabolic—androgenic steroid use in women. Psychother Psy-chosom 2000; 69:19–26
  • Brower KJ: Withdrawal from anabolic steroids. Curr Ther En-docrinol Metab 1997; 6:338–343
  • Cooper CJ, Noakes TD, Dunne T, Lambert MI, Rochford K: A high prevalence of abnormal personality traits in chronic users of anabolic—androgenic steroids. Br J Sports Med 1996; 30:246–250
  • Parssinen M, Kujala U, Vartiainen E, Sama S, Seppala T: In-creased premature mortality of competitive powerlifters sus-pected to have used anabolic agents. Int J Sports Med 2000; 21:225–227
  • Thiblin I, Runeson B, Rajs .1: Anabolic androgenic steroids and suicide. Ann Clin Psychiatry 1999; 11: 223–231
  • Giorgi A, Weatherby RP, Morphy PW: Muscular strength, body composition, and health responses to the use of testosterone enanthate: A double blind study. J Sci Med Sport 1999; 2:341–355
  • Pope HG, Jr, Kouri EM, Hudson .11: Effects of supraphysio-logic doses of testosterone on mood and aggression in nor-mal men: A randomized controlled trial. Arch Gen Psychiatry 2000; 57: 133–140
  • O'Connor DB, Archer J, Hair WM, Wu FC: Exogenous testos-terone, aggression, and mood in eugonadal and hypogonadal men. Physiol Behav 2002; 75:557–566
  • Yates WR, Perry PJ, MacIndoe J, Holman T, Ellingrod V: Psy-chosexual effects of three doses of testosterone cycling in nor-mal men. Biol Psychiatry 1999; 45:254–260
  • Spitzer RL, Williams .TBW, Gibbon M, First MB: The struc-tured clinical interview for DSM-III-R. I. History, rationale and description. Arch Gen Psychiatry 1992; 49:624–629
  • McNair DM, Lorr M, Droppleman LF: Profile of Mood States Manual. San Diego, CA: Educational and Industrial Testing Service; 1981
  • Beck A, Steer R, Garbin M: Psychometric properties of the Beck Depression Inventory. Clin Psychol Rev 1988; 8:77–100
  • Buss AH, Durkee A: An inventory for assessing different kinds of hostility.J Consult Psychol 1957; 21:343–349
  • Kammerer RC, Merdink IL, Jagels M, Catlin DH, Hui KK: Testing for fitioxymesterone (Halotestin) administra-tion to man: Identification of urinary metabolites by gas chromatography—mass spectrometry. J Steroid Biochem 1990; 36:659–666

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.